| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |